Faculty Publications I

2. Arango, C., E. Maloney, M. T. Rugeles, E. Bernal, C. Bernal, I. Borrero, S. Herrera, M. Restrepo, A. Espinal, and W. A. Blattner. 1999. HTLV-I and HTLV-II coexist among the Embera and Inga Amerindians of Colombia [letter]. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 20:102.

3. Bellon, T., A. B. Heredia, M. Llano, A. Minguela, A. Rodriguez, M. Lopez-Botet, and P. Aparicio. 1999. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer. J. Immunol. 162:3996.

4. Carbonetti, N. H., T. J. Irish, C. H. Chen, C. B. O'Connell, G. A. Hadley, U. McNamara, R. G. Tuskan, and G. K. Lewis. 1999. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway. Infect. Immun. 67:602.

5. Fantuzzi, L., P. Borghi, V. Ciolli, G. Pavlakis, F. Belardelli, and S. Gessani. 1999. Loss of CCR2 Expression and Functional Response to Monocyte Chemotactic Protein (MCP-1) During the Differentiation of Human Monocytes: Role of Secreted MCP-1 in the Regulation of the Chemotactic Response. Blood 94:875.

6. Furth, P. A. 1999. Introduction: mammary gland involution and apoptosis of mammary epithelial cells [In Process Citation]. J. Mammary. Gland. Biol. Neoplasia. 4:123.

7. Gallo, R. C. 1999. Tat as one key to HIV-induced immune pathogenesis and pat toxoid as an important component of a vaccine [In Process Citation]. Proc. Natl. Acad. Sci. U. S. A. 96:8324.

8. Gallo, R. C. 1999. A personal perspective on HIV-AIDS research [In Process Citation]. J. Hum. Virol. 2:8.

9. Gobbi, A., C. A. Stoddart, M. S. Malnati, G. Locatelli, F. Santoro, N. W. Abbey, C. Bare, V. Linquist-Stepps, M. B. Moreno, B. G. Herndier, P. Lusso, and J. M. McCune. 1999. Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID- hu Thy/Liv mice [In Process Citation]. J. Exp. Med. 189:1953.

10. Gringeri, A., E. Santagostino, M. Muca-Perja, H. Le Buanec, B. Bizzini, A. Lachgar, J. F. Zagury, J. Rappaport, A. Burny, R. C. Gallo, and D. Zagury. 1999. Tat toxoid as a component of a preventive vaccine in seronegative subjects. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 20:371.

11. Leclercq, I., F. Mortreux, F. Morschhauser, P. Duthilleul, C. Desgranges, A. Gessain, M. Cavrois, J. P. Vernant, O. Hermine, and E. Wattel. 1999. Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia/lymphoma (ATLL). Br. J. Haematol. 105:743.

12. Levine, P. H., H. Dosik, E. M. Joseph, S. Felton, M. A. Bertoni, J. Cervantes, V. Moulana, A. B. Miotti, L. J. Goberdhan, S. L. Lee, A. Daouad, M. DaCosta, E. S. Jaffe, C. A. Axiotis, F. R. Cleghorn, A. Kahn, and S. L. Welles. 1999. A study of adult T-cell leukemia/lymphoma incidence in central Brooklyn. Int. J. Cancer 80:662.

13. Luzar, B., M. Popovic, and A. Cerar. 1999. Infantile HIV encephalopathy associated with cerebral and cerebellar telangiectases [In Process Citation]. Neuropathol. Appl. Neurobiol. 25:72.

14. Mas, A., T. Espanol, A. Heredia, M. A. Pedraza, M. Hernandez, I. Caragol, M. Fernando, J. M. Bertran, J. Alcami, and V. Soriano. 1999. CCR5 genotype and HIV-1 infection in perinatally-exposed infants [In Process Citation]. J. Infect. 38:9.

15. Oldach, D. 1999. "Real-time" polymerase chain reaction [editorial; comment]. Gastroenterology 116:763.

16. Pfundstein, J., M. C. Roghmann, R. S. Schwalbe, S. Q. Qaiyumi, R. J. McCarter,Jr., S. Keay, E. Schweitzer, S. T. Bartlett, J. G. Morris,Jr., and D. W. Oldach. 1999. A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients [In Process Citation]. Clin. Transplant. 13:245.

17. Polo, S., F. Veglia, M. S. Malnati, C. Gobbi, P. Farci, R. Raiteri, A. Sinicco, and P. Lusso. 1999. Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection [In Process Citation]. AIDS 13:447.

18. Ratto-Kim, S., K. V. Sitz, R. P. Garner, J. H. Kim, C. Davis, N. Aronson, N. Ruiz, K. Tencer, R. R. Redfield, and D. L. Birx. 1999. Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response. J. Infect. Dis. 179:337.

19. Samaniego, F., J. L. Bryant, N. Liu, J. E. Karp, A. L. Sabichi, A. Thierry, Y. Lunardi-Iskandar, and R. C. Gallo. 1999. Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin [see comments]. J. Natl. Cancer Inst. 91:135.

20. Schorr, K., M. Li, S. Krajewski, J. C. Reed, and P. A. Furth. 1999. Bcl-2 gene family and related proteins in mammary gland involution and breast cancer [In Process Citation]. J. Mammary. Gland. Biol. Neoplasia. 4:153.

21. Schorr, K., M. Li, U. Bar-Peled, A. Lewis, A. Heredia, B. Lewis, C. M. Knudson, S. J. Korsmeyer, R. Jager, H. Weiher, and P. A. Furth. 1999. Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivo. Cancer Res. 59:2541.

22. Secchiero, P., D. Zella, S. Capitani, R. C. Gallo, and G. Zauli. 1999. Extracellular HIV-1 tat protein Up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells [In Process Citation]. J. Immunol. 162:2427.

23. Sloand, E. M., P. N. Kumar, S. Kim, A. Chaudhuri, F. F. Weichold, and N. S. Young. 1999. Human Immunodeficiency Virus Type 1 Protease Inhibitor Modulates Activation of Peripheral Blood CD4(+) T Cells and Decreases Their Susceptibility to Apoptosis In Vitro and In Vivo. Blood 94:1021.

24. Stiehm, E. R., J. S. Lambert, L. M. Mofenson, J. Bethel, J. Whitehouse, R. Nugent, J. Moye,Jr., M. Glenn Fowler, B. J. Mathieson, P. Reichelderfer, G. J. Nemo, J. Korelitz, W. A. Meyer,3rd, C. V. Sapan, E. Jimenez, J. Gandia, G. Scott, M. J. O'Sullivan, A. Kovacs, A. Stek, W. T. Shearer, and H. Hammill. 1999. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185. J. Infect. Dis. 179:567.

25. Vallejo, A., A. Mas, A. Heredia, C. Altisent, I. Lorenzo, V. Soriano, and I. K. Hewlett. 1999. V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohort with long-term non-progressive infection [letter] [In Process Citation]. AIDS 13:532.

26. Weintraub, B. D. and M. W. Szkudlinski. 1999. Development and in vitro characterization of human recombinant thyrotropin. Thyroid. 9:447.

27. Zauli, G., D. Gibellini, P. Secchiero, H. Dutartre, D. Olive, S. Capitani, and Y. Collette. 1999. Human immunodeficiency virus type 1 nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway [In Process Citation]. Blood 93:1000.

28. Ascon, M. A., D. M. Hone, N. Walters, and D. W. Pascual. 1998. Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity. Infect. Immun. 66:5470.

29. Bansal, J., J. He, P. O. Yarbough, S. Sen, N. T. Constantine, and D. Sen. 1998. Hepatitis E virus infection in eastern India. Am. J. Trop. Med. Hyg. 59:258.

30. Bartholomew, C., N. Jack, J. Edwards, W. Charles, D. Corbin, F. R. Cleghorn, and W. A. Blattner. 1998. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Hum. Virol. 1:302.

31. Benson, J., C. Chougnet, M. Robert-Guroff, D. Montefiori, P. Markham, G. Shearer, R. C. Gallo, M. Cranage, E. Paoletti, K. Limbach, D. Venzon, J. Tartaglia, and G. Franchini. 1998. Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure. J. Virol. 72:4170.

32. Bertolaso, L., D. Gibellini, P. Secchiero, M. Previati, D. Falgione, G. Visani, R. Rizzoli, S. Capitani, and G. Zauli. 1998. Accumulation of catalytically active PKC-zeta into the nucleus of HL-60 cell line plays a key role in the induction of granulocytic differentiation mediated by all-trans retinoic acid. Br. J. Haematol. 100:541.

33. Burns, J. M., R. C. Gallo, A. L. DeVico, and G. K. Lewis. 1998. A New Monoclonal Antibody, mAb 4A12, Identifies a Role for the Glycosaminoglycan (GAG) Binding Domain of RANTES in the Antiviral Effect against HIV-1 and Intracellular Ca2+ Signaling. J. Exp. Med. 188:1917.

34. Cara, A., S. M. Rybak, D. L. Newton, R. Crowley, S. E. Rottschafer, M. S. Reitz,Jr., and G. L. Gusella. 1998. Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector. Gene Ther. 5:65.

35. Cavrois, M., I. Leclercq, O. Gout, A. Gessain, S. Wain-Hobson, and E. Wattel. 1998. Persistent oligoclonal expansion of human T-cell leukemia virus type 1- infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy [In Process Citation]. Oncogene 17:77.

36. Cleghorn, F. R., N. Jack, J. R. Murphy, J. Edwards, B. Mahabir, R. Paul, T. O'Brien, M. Greenberg, K. Weinhold, C. Bartholomew, R. Brookmeyer, and W. A. Blattner. 1998. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population. Am. J. Epidemiol. 147:834.

39. Conant, K., A. Garzino-Demo, A. Nath, J. C. McArthur, W. Halliday, C. Power, R. C. Gallo, and E. O. Major. 1998. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. U. S. A. 95:3117.

40. Dada, A. J., A. O. Ajayi, L. Diamondstone, T. C. Quinn, W. A. Blattner, and R. J. Biggar. 1998. A serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria. Sex. Transm. Dis. 25:237.

41. Dimitrijevic, M., M. Popovic, D. Stefanovic, and M. Petronijevic. 1998. Intravenous immunoglobulin preparations as immunomodulatory agents. Vojnosanit. Pregl. 55:63.

42. DiPaolo, J. A., C. D. Woodworth, F. Coutlee, D. B. Zimonic, J. Bryant, and A. Kessous. 1998. Relationship of stable integration of herpes simplex virus-2 Bg/II N subfragment Xho2 to malignant transformation of human papillomavirus- immortalized cervical keratinocytes. Int. J. Cancer 76:865.

43. Dolei, A., A. Biolchini, C. Serra, S. Curreli, E. Gomes, and F. Dianzani. 1998. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines. AIDS 12:183.

44. Fiorelli, V., R. Gendelman, M. C. Sirianni, H. K. Chang, S. Colombini, P. D. Markham, P. Monini, J. Sonnabend, A. Pintus, R. C. Gallo, and B. Ensoli. 1998. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood 91:956.

45. Flamand, L., R. W. Crowley, P. Lusso, S. Colombini-Hatch, D. M. Margolis, and R. C. Gallo. 1998. Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 95:3111.

46. Flamand, L., F. Romerio, M. S. Reitz, and R. C. Gallo. 1998. CD4 promoter transactivation by human herpesvirus 6. J. Virol. 72:8797.

47. Foli, A., R. Maserati, L. Minoli, M. A. Wainberg, R. C. Gallo, J. Lisziewicz, and F. Lori. 1998. Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine [letter] [In Process Citation]. AIDS 12:1113.

48. Funkhouser, A. W., P. J. Katzman, J. Z. Sickel, and J. S. Lambert. 1998. CD30-positive anaplastic large cell lymphoma (ALCL) of T-cell lineage in a 14-month-old infant with perinatally acquired HIV-1 infection. J. Pediatr. Hematol. Oncol. 20:556.

49. Furth, P. A. 1998. SV40 rodent tumour models as paradigms of human disease: transgenic mouse models [In Process Citation]. Dev. Biol. Stand. 94:281-7:281.

50. Furth, P. A., M. Li, and L. Hennighausen. 1998. Studying development of disease through temporally controlled gene expression in the salivary gland. Ann. N. Y. Acad. Sci. 842:181-7:181.

51. Gallo, R. 1998. The world of HIV and disease, and some new approaches to block it. Bull. Mem. Acad. R. Med. Belg. 153:339.

52. Gallo, R. C. 1998. Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma. J. Natl. Cancer Inst. Monogr. 55.

53. Gallo, R. C. 1998. The enigmas of Kaposi's sarcoma. Science 282:1837.

54. Gallo, R. C., J. Bryant, and Y. Lundardi-Iskandar. 1998. Antitumor effects of hCG in KS [letter; comment]. Nat. Biotechnol. 16:218.

55. Gallo, R. C. 1998. The enigmas of Kaposi's sarcoma. Science 282:1837.

56. Gallo, R. C. 1998. Post-HAART therapy research [editorial] [In Process Citation]. J. Hum. Virol. 1:67.

57. Gallo, R. C. 1998. HIV-1, HHV-8, and Kaposi's sarcoma [editorial; comment]. J. Hum. Virol. 1:185.

58. Gao, F., D. L. Robertson, C. D. Carruthers, S. G. Morrison, B. Jian, Y. Chen, F. Barre-Sinoussi, M. Girard, A. Srinivasan, A. G. Abimiku, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1998. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J. Virol. 72:5680.

59. Garzino-Demo, A., A. L. DeVico, F. Cocchi, and R. C. Gallo. 1998. Beta-chemokines and protection from HIV type 1 disease [In Process Citation]. AIDS Res. Hum. Retroviruses 14 Suppl 2:S177-84:S177.

60. Garzino-Demo, A., A. L. DeVico, and R. C. Gallo. 1998. Chemokine receptors and chemokines in HIV infection [In Process Citation]. J. Clin. Immunol. 18:243.

61. Golub, J. E., D. T. Haselow, J. C. Hageman, A. S. Lopez, D. W. Oldach, L. M. Grattan, and T. M. Perl. 1998. Pfiesteria in Maryland: preliminary epidemiologic findings. Md. Med. J. 47:137.

62. Gong, D. W., S. Bi, B. D. Weintraub, and M. Reitman. 1998. Rat mitochondrial glycerol-3-phosphate dehydrogenase gene: multiple promoters, high levels in brown adipose tissue, and tissue-specific regulation by thyroid hormone. DNA Cell Biol. 17:301.

63. Graham, B. S., M. J. McElrath, R. I. Connor, D. H. Schwartz, G. J. Gorse, M. C. Keefer, M. J. Mulligan, T. J. Matthews, S. M. Wolinsky, D. C. Montefiori, S. H. Vermund, J. S. Lambert, L. Corey, R. B. Belshe, R. Dolin, P. F. Wright, B. T. Korber, M. C. Wolff, and P. E. Fast. 1998. Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J. Infect. Dis. 177:310.

64. Grattan, L. M., D. Oldach, J. K. Tracy, and D. R. Greenberg. 1998. Neurobehavioral complaints of symptomatic persons exposed to Pfiesteria piscicida or morphologically related organisms. Md. Med. J. 47:127.

65. Grattan, L. M., D. Oldach, T. M. Perl, M. H. Lowitt, D. L. Matuszak, C. Dickson, C. Parrott, R. C. Shoemaker, C. L. Kauffman, M. P. Wasserman, J. R. Hebel, P. Charache, and J. G. Morris,Jr. 1998. Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates. Lancet 352:532.

66. Grattan, L. M., D. Oldach, T. M. Perl, M. H. Lowitt, D. L. Matuszak, C. Dickson, C. Parrott, R. C. Shoemaker, C. L. Kauffman, M. P. Wasserman, J. R. Hebel, P. Charache, and J. G. Morris,Jr. 1998. Learning and memory difficulties after environmental exposure to waterways containing toxin-producing Pfiesteria or Pfiesteria-like dinoflagellates. Lancet 352:532.

67. Gringeri, A., E. Santagostino, M. Muca-Perja, P. M. Mannucci, J. F. Zagury, B. Bizzini, A. Lachgar, M. Carcagno, J. Rappaport, M. Criscuolo, W. Blattner, A. Burny, R. C. Gallo, and D. Zagury. 1998. Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV- 1-infected patients [see comments]. J. Hum. Virol. 1:293.

68. Grossmann, M., H. Leitolf, B. D. Weintraub, and M. W. Szkudlinski. 1998. A rational design strategy for protein hormone superagonists. Nat. Biotechnol. 16:871.

69. Grossmann, M., H. Leitolf, B. D. Weintraub, and M. W. Szkudlinski. 1998. A rational design strategy for protein hormone superagonists [In Process Citation]. Nat. Biotechnol. 16:871.

70. Halsey, N. A., J. S. Coberly, J. Desormeaux, P. Losikoff, J. Atkinson, L. H. Moulton, M. Contave, M. Johnson, H. Davis, L. Geiter, E. Johnson, R. Huebner, R. Boulos, and R. E. Chaisson. 1998. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet 351:786.

71. Heredia, A., A. Vallejo, V. Soriano, A. Silva, K. Mansinho, S. Fevereiro, A. Mas, M. Gutierrez, J. S. Epstein, and I. K. Hewlett. 1998. Phylogenetic analysis of HIV type 2 strains from Portugal [letter]. AIDS Res. Hum. Retroviruses 14:471.

72. Heredia, A., A. Vallejo, V. Soriano, A. Aguilera, E. Caballero, J. S. Epstein, and I. K. Hewlett. 1998. Genetic analysis of human immunodeficiency virus type 2 strains from Spain. AIDS Res. Hum. Retroviruses 14:91.

73. Hermans, P., N. Clumeck, O. Picard, J. P. Vooren, P. Duriez, D. Zucman, J. L. Bryant, P. Gill, Y. Lunardi-Iskandar, and R. C. Gallo. 1998. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations [In Process Citation]. J. Hum. Virol. 1:82.

74. Hill, C. M., D. Kwon, M. Jones, C. B. Davis, S. Marmon, B. L. Daugherty, J. A. DeMartino, M. S. Springer, D. Unutmaz, and D. R. Littman. 1998. The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins. Virology 248:357.

75. Hone, D. M., J. Powell, R. W. Crowley, D. Maneval, and G. K. Lewis. 1998. Lipopolysaccharide from an Escherichia coli htrB msbB mutant induces high levels of MIP-1 alpha and MIP-1 beta secretion without inducing TNF-alpha and IL-1 beta [In Process Citation]. J. Hum. Virol. 1:251.

76. Janssen, R. S., G. A. Satten, S. L. Stramer, B. D. Rawal, T. R. O'Brien, B. J. Weiblen, F. M. Hecht, N. Jack, F. R. Cleghorn, J. O. Kahn, M. A. Chesney, and M. P. Busch. 1998. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280:42.

77. Kane, A. S., D. Oldach, and R. Reimschuessel. 1998. Fish lesions in the Chesapeake Bay: Pfiesteria-like dinoflagellates and other etiologies. Md. Med. J. 47:106.

78. Keay, S., D. Oldach, A. Wiland, D. Klassen, E. Schweitzer, L. V. Abruzzo, D. Kumar, and S. Bartlett. 1998. Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipients. Clin. Infect. Dis. 26:596.

79. Khaksa, G., K. Nalini, M. Bhat, and N. Udupa. 1998. High-performance liquid chromatographic determination of insulin in rat and human plasma [In Process Citation]. Anal. Biochem. 260:92.

80. La Grenade, L., A. Manns, V. Fletcher, D. Derm, C. Carberry, B. Hanchard, E. M. Maloney, B. Cranston, N. P. Williams, R. Wilks, E. C. Kang, and W. A. Blattner. 1998. Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children [see comments]. Arch. Dermatol. 134:439.

81. Lambert, J. 1998. Tat toxoid: its potential role as an HIV vaccine [editorial; comment]. J. Hum. Virol. 1:249.

82. Leclercq, I., M. Cavrois, F. Mortreux, O. Hermine, A. Gessain, F. Morschhauser, and E. Wattel. 1998. Oligoclonal proliferation of human T-cell leukaemia virus type 1 bearing T cells in adult T-cell leukaemia/lymphoma without deletion of the 3' provirus integration sites [In Process Citation]. Br. J. Haematol. 101:500.

83. Loomis-Price, L. D., J. H. Cox, J. R. Mascola, T. C. VanCott, N. L. Michael, T. R. Fouts, R. R. Redfield, M. L. Robb, B. Wahren, H. W. Sheppard, and D. L. Birx. 1998. Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection. J. Infect. Dis. 178:1306.

84. Lunardi-Iskandar, Y., J. L. Bryant, W. A. Blattner, C. L. Hung, L. Flamand, P. Gill, P. Hermans, S. Birken, and R. C. Gallo. 1998. Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease [see comments]. Nat. Med. 4:428.

85. Maloney, E. M., F. R. Cleghorn, O. S. Morgan, P. Rodgers-Johnson, B. Cranston, N. Jack, W. A. Blattner, C. Bartholomew, and A. Manns. 1998. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 17:167.

86. Mann, D. L., R. P. Garner, D. E. Dayhoff, K. Cao, M. A. Fernandez-Vina, C. Davis, N. Aronson, N. Ruiz, D. L. Birx, and N. L. Michael. 1998. Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans. J. Infect. Dis. 178:1799.

87. Manns, A., B. Hanchard, O. S. Morgan, R. Wilks, B. Cranston, J. M. Nam, M. Blank, M. Kuwayama, S. Yashiki, T. Fujiyoshi, W. Blattner, and S. Sonoda. 1998. Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia/lymphoma in a Black population. J. Natl. Cancer Inst. 90:617.

88. Mitrovic, D., M. Popovic, D. Stefanovic, M. Cirkovic, B. Glisic, L. Pavlica, R. Popovic, and N. Pejnovic. 1998. Antiphospholipid syndrome in systemic connective tissue diseases [In Process Citation]. Vojnosanit. Pregl. 55:29.

89. Mitrovic, D., M. Popovic, B. Glisic, L. Pavlica, and M. Dimitrijevic. 1998. Cyclosporine in the treatment of autoimmune disorders: a 10-year experience. Transplant. Proc. 30:4134.

90. Mojsilovic, A., M. Popovic, S. Markovic, and M. Krstic. 1998. Characterization of visually similar diffuse diseases from B-scan liver images using nonseparable wavelet transform. IEEE Trans. Med. Imaging 17:541.

91. Mundy, L. M., D. Oldach, P. G. Auwaerter, C. A. Gaydos, R. D. Moore, J. G. Bartlett, and T. C. Quinn. 1998. Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team [see comments]. Chest 113:1201.

92. Nagashunmugam, T., D. Malamud, C. Davis, W. R. Abrams, and H. M. Friedman. 1998. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus. J. Infect. Dis. 178:1635.

93. Nicholas, J., J. C. Zong, D. J. Alcendor, D. M. Ciufo, L. J. Poole, R. T. Sarisky, C. J. Chiou, X. Zhang, X. Wan, H. G. Guo, M. S. Reitz, and G. S. Hayward. 1998. Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8. J. Natl. Cancer Inst. Monogr. 79.

94. Nogueira, S. A., M. J. Caiuby, V. Vasconcelos, M. Halpern, C. Gouveia, B. Thorpe, C. Ramparini, J. M. Macieira, and J. S. Lambert. 1998. Paracoccidioidomycosis and tuberculosis in AIDS patients: report of two cases in Brazil. Int. J. Infect. Dis. 2:168.

95. Olaitan, A., M. A. Johnson, W. M. Reid, and L. W. Poulter. 1998. Changes to the cytokine microenvironment in the genital tract mucosa of HIV+ women. Clin. Exp. Immunol. 112:100.

96. Oldach, D., E. Brown, and P. Rublee. 1998. Strategies for environmental monitoring of toxin producing phantom dinoflagellates in the Chesapeake. Md. Med. J. 47:113.

97. Oldach, D. 1998. GB virus-C (hepatitis G virus) nostalgia [editorial; comment]. Kidney Int. 53:1809.

98. Oldach, D. W., R. E. Richard, E. N. Borza, and R. M. Benitez. 1998. A mysterious death [see comments]. N. Engl. J. Med. 338:1764.

99. Owman, C., A. Garzino-Demo, F. Cocchi, M. Popovic, A. Sabirsh, and R. C. Gallo. 1998. The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. Proc. Natl. Acad. Sci. U. S. A. 95:9530.

100. Popovic, D. and M. Popovic. 1998. Tuning of a nonanalytical hierarchical control system for reaching with FES. IEEE Trans. Biomed. Eng. 45:203.

101. Popovic, M., T. Hrzenjak, M. Grdisa, and S. Vukovic. 1998. Adhesins of immunoglobulin-like superfamily from earthworm Eisenia foetida. Gen. Pharmacol. 30:795.

102. Ryan, L. K., J. Rhodes, M. Bhat, and G. Diamond. 1998. Expression of beta-defensin genes in bovine alveolar macrophages. Infect. Immun. 66:878.

103. Samaniego, F., P. D. Markham, R. Gendelman, Y. Watanabe, V. Kao, K. Kowalski, J. A. Sonnabend, A. Pintus, R. C. Gallo, and B. Ensoli. 1998. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am. J. Pathol. 152:1433.

104. Satoh, T., L. M. Brown, W. A. Blattner, E. M. Maloney, C. C. Kurman, D. L. Nelson, D. Fuchs, H. Wachter, D. J. Tollerud, M. E. Willy, D. R. Hoover, N. A. Halsey, E. J. Pate, S. Z. Wiktor, and A. Manns. 1998. Serum neopterin, beta2-microglobulin, soluble interleukin-2 receptors, and immunoglobulin levels in healthy adolescents Relationship between unsupplemented vitamin A serum concentrations and measles vaccine response in Jamaican children. Pediatr. Infect. Dis. J. 17:526.

105. Secchiero, P., L. D. Bonino, P. Lusso, M. C. Abele, G. Reato, S. Kerim, G. Palestro, G. Zauli, and G. Valente. 1998. Human herpesvirus type 7 in Hodgkin's disease. Br. J. Haematol. 101:492.

106. Secchiero, P., L. Bertolaso, L. Casareto, D. Gibellini, M. Vitale, K. Bemis, A. Aleotti, S. Capitani, G. Franchini, R. C. Gallo, and G. Zauli. 1998. Human herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4(+) T cells. Blood 92:1685.

107. Secchiero, P., L. D. Bonino, P. Lusso, M. C. Abele, G. Reato, S. Kerim, G. Palestro, G. Zauli, and G. Valente. 1998. Human herpesvirus type 7 in Hodgkin's disease [In Process Citation]. Br. J. Haematol. 101:492.

108. Secchiero, P., L. Bertolaso, D. Gibellini, D. Ricci, K. Bemis, S. Capitani, R. C. Gallo, and G. Zauli. 1998. Enforced expression of human bcl-2 in CD4+ T cells enhances human herpesvirus 7 replication and induction of cytopathic effects. Eur. J. Immunol. 28:1587.

109. Secchiero, P., D. Zella, O. Barabitskaja, M. S. Reitz, S. Capitani, R. C. Gallo, and G. Zauli. 1998. Progressive and persistent downregulation of surface CXCR4 in CD4(+) T cells infected with human herpesvirus 7. Blood 92:4521.

110. Sloand, E. M., J. P. Maciejewski, T. Sato, J. Bruny, P. Kumar, S. Kim, F. F. Weichold, and N. S. Young. 1998. The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection. J. Clin. Invest. 101:195.

111. Tracy, J. K., D. Oldach, D. R. Greenberg, and L. M. Grattan. 1998. Psychologic adjustment of watermen with exposure of Pfiesteria piscicida. Md. Med. J. 47:130.

112. Vallejo, A., A. Heredia, A. Mas, S. F. Lee, J. S. Epstein, V. Soriano, and I. K. Hewlett. 1998. Tropism, coreceptor use, and phylogenetic analysis of both the V3 loop and the protease gene of three novel HIV-1 group O isolates. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 18:417.

113. VanCott, J. L., S. N. Chatfield, M. Roberts, D. M. Hone, E. L. Hohmann, D. W. Pascual, M. Yamamoto, H. Kiyono, and J. R. McGhee. 1998. Regulation of host immune responses by modification of Salmonella virulence genes. Nat. Med. 4:1247.

114. Vanhems, P., J. Lambert, D. A. Cooper, L. Perrin, A. Carr, B. Hirschel, J. Vizzard, S. Kinloch-de Loes, and R. Allard. 1998. Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship. Clin. Infect. Dis. 26:323.

115. Weichold, F. F., D. Zella, O. Barabitskaja, J. P. Maciejewski, D. E. Dunn, E. M. Sloand, and N. S. Young. 1998. Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most- primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood 91:907.

116. Weinstein, D. L., B. L. O'Neill, D. M. Hone, and E. S. Metcalf. 1998. Differential early interactions between Salmonella enterica serovar Typhi and two other pathogenic Salmonella serovars with intestinal epithelial cells. Infect. Immun. 66:2310.

117. Willy, M. E., D. R. Hoover, N. A. Halsey, E. M. Maloney, E. J. Pate, S. Z. Wiktor, W. A. Blattner, and A. Manns. 1998. Relationship between unsupplemented vitamin A serum concentrations and measles vaccine response in Jamaican children [In Process Citation]. Pediatr. Infect. Dis. J. 17:526.

118. Zagury, D., A. Lachgar, V. Chams, L. S. Fall, J. Bernard, J. F. Zagury, B. Bizzini, A. Gringeri, E. Santagostino, J. Rappaport, M. Feldman, S. J. O'Brien, A. Burny, and R. C. Gallo. 1998. C-C chemokines, pivotal in protection against HIV type 1 infection. Proc. Natl. Acad. Sci. U. S. A. 95:3857.

119. Zagury, D., A. Lachgar, V. Chams, L. S. Fall, J. Bernard, J. F. Zagury, B. Bizzini, A. Gringeri, E. Santagostino, J. Rappaport, M. Feldman, A. Burny, and R. C. Gallo. 1998. Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc. Natl. Acad. Sci. U. S. A. 95:3851.

120. Zagury, J. F., A. Sill, W. Blattner, A. Lachgar, H. Le Buanec, M. Richardson, J. Rappaport, H. Hendel, B. Bizzini, A. Gringeri, M. Carcagno, M. Criscuolo, A. Burny, R. C. Gallo, and D. Zagury. 1998. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine [see comments]. J. Hum. Virol. 1:282.

121. Zauli, G., D. Gibellini, M. Vitale, P. Secchiero, C. Celeghini, A. Bassini, S. Pierpaoli, M. Marchisio, L. Guidotti, and S. Capitani. 1998. The induction of megakaryocyte differentiation is accompanied by selective ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34(+) cells [In Process Citation]. Blood 92:472.

122. Zella, D., A. Riva, F. F. Weichold, M. S. Reitz,Jr., and G. Gerna. 1998. A novel sensitive assay to define immune status using short-term peripheral blood derived cell culture and dual-color flow cytometry. Immunol. Lett. 62:45.

123. Zella, D., O. Barabitskaja, J. M. Burns, F. Romerio, D. E. Dunn, M. G. Revello, G. Gerna, M. S. Reitz,Jr., R. C. Gallo, and F. F. Weichold. 1998. Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. Blood 91:4444.

124. Abdel-Hamid, M., D. C. Edelman, W. E. Highsmith, and N. T. Constantine. 1997. Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. J. Hum. Virol. 1:58.

125. Bartholomew, C., F. Cleghorn, N. Jack, J. Edwards, and W. Blattner. 1997. Human T-cell lymphotropic virus type I-associated facial nerve palsy in Trinidad and Tobago. Ann. Neurol. 41:806.

126. Bhat, M. K., Yu Cl, N. Yap, Q. Zhan, Y. Hayashi, P. Seth, and S. Cheng. 1997. Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways. J. Biol. Chem. 272:28989.

127. Blasig, C., C. Zietz, B. Haar, F. Neipel, S. Esser, N. H. Brockmeyer, E. Tschachler, S. Colombini, B. Ensoli, and M. Sturzl. 1997. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71:7963.

128. Borriello, F., J. Lederer, S. Scott, and A. H. Sharpe. 1997. MRC OX-2 defines a novel T cell costimulatory pathway. J. Immunol. 158:4548.

129. Brau, N., H. L. Leaf, R. L. Wieczorek, and D. M. Margolis. 1997. Severe hepatitis in three AIDS patients treated with indinavir [letter; comment]. Lancet 349:924.